United Therapeutics Corporation
NASDAQ:UTHR
351.33 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,327.5 | 1,936.3 | 1,685.5 | 1,483.3 | 1,448.8 | 1,627.8 | 1,725.3 | 1,598.8 | 1,465.761 | 1,288.519 | 1,116.984 | 916.076 | 743.183 | 603.831 | 369.848 | 281.497 | 210.943 | 159.632 | 115.915 | 73.59 | 53.341 | 30.12 | 5.732 | 2.049 | 0.4 | 0.1 |
| Cost of Revenue
| 257.5 | 146.7 | 122.5 | 108.1 | 117.6 | 198.7 | 105.7 | 72.7 | 69.036 | 125.883 | 131.127 | 119.297 | 88.904 | 73.465 | 45.321 | 30.066 | 22.261 | 17.028 | 12.315 | 8.25 | 6.783 | 5.456 | 3.137 | 1.706 | 1.4 | 0 |
| Gross Profit
| 2,070 | 1,789.6 | 1,563 | 1,375.2 | 1,331.2 | 1,429.1 | 1,619.6 | 1,526.1 | 1,396.725 | 1,162.636 | 985.857 | 796.779 | 654.279 | 530.366 | 324.527 | 251.431 | 188.682 | 142.604 | 103.6 | 65.34 | 46.558 | 24.664 | 2.595 | 0.343 | -1 | 0.1 |
| Gross Profit Ratio
| 0.889 | 0.924 | 0.927 | 0.927 | 0.919 | 0.878 | 0.939 | 0.955 | 0.953 | 0.902 | 0.883 | 0.87 | 0.88 | 0.878 | 0.877 | 0.893 | 0.894 | 0.893 | 0.894 | 0.888 | 0.873 | 0.819 | 0.453 | 0.168 | -2.5 | 1 |
| Reseach & Development Expenses
| 408 | 322.9 | 540.1 | 357.7 | 1,182.6 | 357.9 | 264.6 | 147.6 | 245.098 | 242.549 | 299.348 | 173.387 | 180.015 | 166.761 | 122.188 | 239.181 | 83.352 | 57.57 | 36.052 | 30.602 | 35.417 | 26.778 | 32.59 | 70.188 | 30.7 | 11 |
| General & Administrative Expenses
| 395.3 | 416.2 | 402.6 | 369 | 275.5 | 206.7 | 265.8 | 232.2 | 358.315 | 299.287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.442 | 16.943 | 11.736 | 5 | 0 |
| Selling & Marketing Expenses
| 81.8 | 70.8 | 64.4 | 54.9 | 60.7 | 59.1 | 64.3 | 84.6 | 94.297 | 82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.447 | 3,384.376 | 0 | 0 | 0 |
| SG&A
| 477.1 | 487 | 467 | 423.9 | 336.2 | 265.8 | 330.1 | 316.8 | 452.612 | 381.287 | 394.01 | 201.746 | 156.482 | 199.6 | 176.338 | 94.306 | 99.027 | 54.028 | 24.655 | 21.529 | 22.667 | 15.889 | 16.943 | 11.736 | 5 | 2.4 |
| Other Expenses
| -14 | -40.2 | 42.2 | 49.3 | 22.6 | -7.7 | 13.2 | 2.4 | 0.157 | 3.972 | 0.635 | 31.866 | 156.482 | 199.6 | 176.338 | 94.306 | 99.027 | 56.052 | 24.655 | 21.529 | 22.667 | 15.889 | 0 | -0.08 | -1.3 | 2.4 |
| Operating Expenses
| 885.1 | 809.9 | 1,007.1 | 781.6 | 1,518.8 | 623.7 | 594.7 | 464.4 | 697.71 | 623.836 | 693.358 | 375.133 | 336.497 | 366.361 | 298.526 | 333.487 | 182.379 | 113.622 | 60.707 | 52.131 | 58.084 | 42.667 | 49.533 | 81.844 | 34.4 | 13.4 |
| Operating Income
| 1,184.9 | 979.7 | 555.9 | 593.6 | -187.6 | 805.4 | 814.9 | 1,061.7 | 699.015 | 538.8 | 292.499 | 421.646 | 317.782 | 164.005 | 26.001 | -82.056 | 6.303 | 28.982 | 42.893 | 13.209 | -11.526 | -18.003 | -46.939 | -81.501 | -35.4 | -13.3 |
| Operating Income Ratio
| 0.509 | 0.506 | 0.33 | 0.4 | -0.129 | 0.495 | 0.472 | 0.664 | 0.477 | 0.418 | 0.262 | 0.46 | 0.428 | 0.272 | 0.07 | -0.291 | 0.03 | 0.182 | 0.37 | 0.179 | -0.216 | -0.598 | -8.189 | -39.771 | -88.5 | -133 |
| Total Other Income Expenses Net
| -14 | -29.1 | 38 | 45.3 | 22.6 | -61.2 | -246.4 | 2.4 | 350.157 | 3.972 | 0.635 | 31.723 | -0.748 | 0.609 | 0.495 | -1.251 | -1.147 | -1.316 | -0.701 | -0.742 | -0.766 | -10.485 | -0.197 | -4.681 | 0.1 | 0.5 |
| Income Before Tax
| 1,274.3 | 950.6 | 593.9 | 638.9 | -165 | 758.9 | 769.5 | 1,060.2 | 1,044.437 | 525.18 | 278.903 | 440.671 | 299.117 | 147.839 | 18.767 | -72.298 | 16.583 | 39.908 | 47.522 | 15.449 | -9.969 | -23.651 | -37.288 | -86.182 | -35.3 | -12.8 |
| Income Before Tax Ratio
| 0.547 | 0.491 | 0.352 | 0.431 | -0.114 | 0.466 | 0.446 | 0.663 | 0.713 | 0.408 | 0.25 | 0.481 | 0.402 | 0.245 | 0.051 | -0.257 | 0.079 | 0.25 | 0.41 | 0.21 | -0.187 | -0.785 | -6.506 | -42.055 | -88.25 | -128 |
| Income Tax Expense
| 289.5 | 223.3 | 118.1 | 124.1 | -60.5 | 169.7 | 351.6 | 346.5 | 392.798 | 185.106 | 104.343 | 136.229 | 81.874 | 41.923 | -0.695 | -29.509 | -3.276 | -34.057 | -17.494 | -3.025 | -2.51 | 5.439 | -9.651 | -5.892 | -1.9 | 0 |
| Net Income
| 984.8 | 727.3 | 475.8 | 514.8 | -104.5 | 589.2 | 417.9 | 713.7 | 651.639 | 340.074 | 174.56 | 304.442 | 217.868 | 105.916 | 19.462 | -42.789 | 19.859 | 73.965 | 65.016 | 15.449 | -9.969 | -23.651 | -37.288 | -75.608 | -33.5 | -12.8 |
| Net Income Ratio
| 0.423 | 0.376 | 0.282 | 0.347 | -0.072 | 0.362 | 0.242 | 0.446 | 0.445 | 0.264 | 0.156 | 0.332 | 0.293 | 0.175 | 0.053 | -0.152 | 0.094 | 0.463 | 0.561 | 0.21 | -0.187 | -0.785 | -6.506 | -36.896 | -83.75 | -128 |
| EPS
| 21.04 | 15.98 | 10.6 | 11.65 | -2.39 | 13.54 | 9.5 | 16.29 | 14.17 | 7.06 | 3.49 | 5.84 | 3.81 | 1.89 | 0.37 | -0.93 | 0.47 | 1.61 | 1.43 | 0.36 | -0.24 | -0.57 | -0.92 | -1.97 | -1.26 | -0.77 |
| EPS Diluted
| 19.81 | 15 | 10.06 | 11.54 | -2.39 | 13.39 | 9.31 | 15.25 | 12.72 | 6.28 | 3.28 | 5.71 | 3.67 | 1.78 | 0.35 | -0.93 | 0.44 | 1.53 | 1.29 | 0.33 | -0.24 | -0.57 | -0.92 | -1.97 | -1.26 | -0.77 |
| EBITDA
| 1,386.8 | 984.7 | 614.8 | 671.5 | -120.8 | 826.3 | 1,038.1 | 1,064.1 | 699.172 | 542.772 | 296.961 | 484.455 | 321.113 | 166.784 | 31.006 | -71.257 | 8.086 | 31.271 | 45.254 | 15.442 | -9.388 | -4.592 | -43.227 | -76.899 | -36.8 | -13.8 |
| EBITDA Ratio
| 0.596 | 0.509 | 0.365 | 0.453 | -0.083 | 0.508 | 0.602 | 0.666 | 0.477 | 0.421 | 0.266 | 0.529 | 0.432 | 0.276 | 0.084 | -0.253 | 0.038 | 0.196 | 0.39 | 0.21 | -0.176 | -0.152 | -7.542 | -37.525 | -92 | -138 |